Opendata, web and dolomites
H2020 projects about "tuberculosis"
The page lists 64 projects related to the topic "tuberculosis".
| # | |||
|---|---|---|---|
| 1 | complexNMR | Structural Dynamics of Protein Complexes by Solid-State NMR | 2015 |
| 2 | EMI-TB | Eliciting Mucosal Immunity to Tuberculosis | 2015 |
| 3 | PneumoSIP | PneumoSIP – a cost-effective solution for the rapid diagnostic of pneumonia | 2014 |
| 4 | ACfoil | Anti-counterfeit foil for security packaging | 2014 |
| 5 | Fluorobot | Robotic fluorescent microscope for smear slide screening in Tuberculosis Diagnosis | 2014 |
| 6 | PoC-Cycle | Innovative Molecular Diagnostics point-of-care device for MRSA | 2014 |
| 7 | Inflammafish | Cross-talk between inflammation and autophagy in tuberculosis | 2016 |
| 8 | ACPNMR | Structural dynamics of acyl carrier protein complexes through combined solution and solid-state NMR | 2015 |
| 9 | FUNFIT | Fungal resistance to antifungals is promoted by cell heterogeneity | 2015 |
| 10 | HistoricEpi | Quantiative Study of Major Historic Epidemics and Transitions to longer, healthier lives | 2015 |
| 11 | MDR Tuberculosis | Evolution and success of the multi-drug resistant M. tuberculosis SIT41 (LAM7-TUR) lineage | 2015 |
| 12 | MtbTransReg | Translational regulation in the persistence and drug susceptibility of Mycobacterium tuberculosis | 2015 |
| 13 | ADVANTAGE | ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs: a European consortium approach | 2015 |
| 14 | TB-ACCELERATE | Integrating genomics, epidemiology and evolution to accelerate tuberculosis eradication | 2015 |
| 15 | SCENT | SCENT: Hybrid Gels for Rapid Microbial Detection | 2015 |
| 16 | TOPO-TB | TOPO-TB | 2015 |
| 17 | MYCO TRAPS | New roles for the cytoskeleton in cell-autonomous immunity to mycobacteria | 2016 |
| 18 | EndoSubvert | Common mechanisms of host membrane trafficking subversion by intracellular pathogens to rupture bacterial containing vacuoles | 2017 |
| 19 | BREATH | BREATH: Biomarkers for Respiratory diseases detected in Exhaled Air through a new Technological instrument for research and Healthcare markets. | 2016 |
| 20 | anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept | 2017 |
| 21 | MYCONEUTROPHILS | Elucidating the involvement of neutrophils in the pathogenesis of tuberculosis using a zebrafish model | 2017 |
| 22 | PE-FECATS | Pasteur's Empire - French Expertise, Colonialism, and Transnational Science | 2017 |
| 23 | BLMs 4 TB | Beta-lactams for Tuberculosis Treatment | 2018 |
| 24 | bTB-Test | Volatolomics test for the diagnosis of bovine tuberculosis | 2018 |
| 25 | STriTuVaD | In Silico Trial for Tuberculosis Vaccine Development | 2018 |
| 26 | TBornotTB | What is Tuberculosis? Challenging the Current Paradigm of Tuberculosis Natural History using Mathematical Modelling Techniques | 2018 |
| 27 | NovAnI | Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies | 2018 |
| 28 | DynaMO_TB | Spatiotemporal regulation of localization and replication of M. tuberculosis in humanmacrophages | 2018 |
| 29 | NovInDXS | Development of novel inhibitors of the anti-infective target DXS using dynamic combinatorial chemistry (DCC) | 2018 |
| 30 | BREFMC2017 | Deciphering the function(s) of the C-type lectin DCIR/CLEC4A in tuberculosis | 2018 |
| 31 | Mtb CoaBC | CoaBC from the Coenzyme A pathway of Mycobacterium tuberculosis as an antimicrobial drug target | 2018 |
| 32 | NewBorN | Unveiling new B-, N- containing structures through photoredox catalysis | 2018 |
| 33 | MTBHLAE | Investigation of a novel immune cell type in Tuberculosis: characterization of the specificity, function and pathogen killing ability of T cells restricted by non-classical HLA-E molecules | 2018 |
| 34 | PHANTOM | Phenotypic screening the host antimicrobial responses towards the eradication of Mycobacterium tubercuosis | 2018 |
| 35 | iCHEMGENODRUGS_TB | Chemogenomics and in silico repurposing as an innovative approach for rapid drug discovery in tuberculosis | 2018 |
| 36 | GammaDelta | DECIPHERING THE MEMORY OF gd T CELLS: DOES IT HAVE A ROLE IN CROSS-PROTECTION OF BACILLE CALMETTE-GUERIN VACCINATION? | 2018 |
| 37 | PITBUL | Point-of-Care implementation of TB testing with ultra-fast Local Heating PCR | 2017 |
| 38 | Nano4 | Colorimetric Precision Nanodiagnostics made Fast and Affordable | 2018 |
| 39 | MycoRailway | Discovery and molecular investigation of mycobacterial transporters responsible for iron acquisition | 2018 |
| 40 | AMR-TB | Theoretical and computational investigation of tuberculosis antimicrobial resistance development based on extensive experimental library of mycobacterium strains | 2019 |
| 41 | INNOVA4TB | Innovation in Tuberculosis | 2019 |
| 42 | ARREST-TB | Accurate, Rapid, Robust and Economical diagnostic technoliogieS for Tuberculosis | 2019 |
| 43 | ESX-4 T7SS | Structure/function of a prototypic type VII secretion system from a fast-growing pathogenic mycobacteria | 2019 |
| 44 | deCrYPtion | Decrypting Mycobacterium cytochrome P450 (CYP) physiological functions by testing hypotheses emitted form large-scale comparative genomics analysis | 2019 |
| 45 | COMBATTB | Comprehensive Mechanisms of Bacterial Antibiotic Tolerance in Mycobacterium Tuberculosis | 2019 |
| 46 | Lac-TB | Dissecting the impact of Lactate in Tuberculosis | 2020 |
| 47 | TBNANO | Targeted intracellular delivery of antitubercular agents by functionalized nanocapsules | 2019 |
| 48 | Host-TB | Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis | 2019 |
| 49 | LEPVORS | Identification and characterization of new drug resistance and host adaptation mechanisms in Mycobacterium leprae | 2019 |
| 50 | RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors | 2019 |
| 51 | Bio Ring Diagnostics | Bio Ring Diagnostics | 2019 |
| 52 | TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments. | 2019 |
| 53 | EpiShuttle 2.0 | EpiShuttle: Isolation and Transportation of Infectious Disease Patients | 2019 |
| 54 | Tuberculini | A novel in-vitro diagnostic test for drug-resistant tuberculosis and a personalized antibiotic treatment plan. | 2019 |
| 55 | mfloDx | Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection | 2019 |
| 56 | EDAS HEALTHCARE | AI-based infectious diseases diagnosis in seconds | 2019 |
| 57 | COMBINE | Collaboration for Prevention and Treatment of MDR Bacterial Infections | 2019 |
| 58 | EU-PEARL | EU Patient- cEntric clinicAl tRial pLatform | 2019 |
| 59 | SMA-TB | A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients. | 2020 |
| 60 | PANDORA | Pandemics Outbreaks Rationalized: towards a universal therapy to eliminate intracellular pathogens and drug resistance | 2020 |
| 61 | ERA4TB | EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS | 2020 |
| 62 | DRTB-HDT | STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL | 2020 |
| 63 | SpaTime_AnTB | Single-cell spatiotemporal analysis of Mycobacterium tuberculosis responses to antibiotics within host microenvironments | 2020 |
| 64 | ANTIBIOCLICKS | BioInspired Clicked Siderophore-Antibiotics | 2020 |